A major advance in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in several types of malignancies, leading https://bookmarkspecial.com/story22132194/vhh-fragments-reactivate-the-p53-protein-the-new-approach-for-cancer-management